As noted by Wissam G., secondary endpoints included the percentage of patients attaining 5, 10, 15, and 20% weight loss, along with improvements in metabolic, cardiovascular, and comorbidities after 12 months of follow-up
& Carpenter, T
Administered via intramuscular or subcutaneous injection
, zinc l-optizinc , chromium chromemate , acetyl l-carnitine hcl , alpha lipoic acid , coenzyme q10 , grape seed extract , pomegranate extract vitagranate , japanese knotweed extract , benfotiamine , lutein , black pepper extract ( fruit ) bioperine , zeaxanthin ( , from : marigold flower extract ) lutemax